Association of tumor necrosis factor-α gene g-308a polymorphism with dilated cardiomyopathy: A meta-analysis

DNA and Cell Biology

Volumn 32, Issue 3, 2013, Pages 130-137

  Luo, Rong ^a   Li, Xiaoping ^b   Fan, Xiongwei ^a   Yuan, Wuzhou ^a   Wu, Xiushan ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONGESTIVE CARDIOMYOPATHY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE FREQUENCY; GENE MUTATION; GENETIC MODEL; GENETIC RISK; GENOTYPE; HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84874734552     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2012.1911     Document Type: Article

References (46)

1. Alikasifoglu, M., Tokgozoglu, L., Acil, T., Atalar, E., Oto, M.A., Kes, S.S., and Tuncbilek, E. (2003). Tumor necrosis factor- (alpha) polymorphism in Turkish patients with dilated cardiomyopathy. Eur J Heart Fail 5, 161-163.
2. Balakrishnan, V.S., Guo, D., Rao, M., Jaber, B.L., Tighiouart, H., Freeman, R.L., Huang, C., King, A.J., and Pereira, B.J. (2004). Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 65, 1449-1460.
3. Bozkurt, B., Kribbs, S.B., Clubb, F.J., Michael, L.H., Jr., Didenko, V.V., Hornsby, P.J., Seta, Y., Oral, H., Spinale, F.G., and Mann, D.L. (1998). Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97, 1382- 1391.
4. Brooksbank, R., Badenhorst, D., Sliwa, K., Norton, G., and Woodiwiss, A. (2008). The G-308A polymorphism of the TNF- (alpha); gene does not predict changes in cardiac function in response to medical therapy for idiopathic dilated cardiomyopathy. Cardiovasc J Afr 19, 254-258.
5. Bruggink, A.H., van Oosterhout, M.F., De Jonge, N., Gmelig- Meyling, F.H., and De Weger, R.A. (2008). TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device. Transpl Immunol 19, 64-68.
6. Burkett, E.L., and Hershberger, R.E. (2005). Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol 45, 969-981.
7. Charron, P., Arad, M., Arbustini, E., Basso, C., Bilinska, Z., Elliott, P., Helio, T., Keren, A., McKenna, W.J., Monserrat, L., Pankuweit, S., Perrot, A., Rapezzi, C., Ristic, A., Seggewiss, H., Langen, I., and Tavazzi, L. (2010). Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 31, 2715-2728.
8. Colombo, M.G., Botto, N., Vittorini, S., Paradossi, U., and Andreassi, M.G. (2008). Clinical utility of genetic tests for inherited hypertrophic and dilated cardiomyopathies. Cardiovasc Ultrasound 6, 62.
9. Deng, J., Luo, R., and Li, X. (2011). HLA-DRB1 gene polymorphism is associated with idiopathic dilated cardiomyopathy: a meta-analysis. J Cardiovasc Med (Hagerstown) 12, 648-652.
10. Elliott, P., Andersson, B., Arbustini, E., Bilinska, Z., Cecchi, F., Charron, P., Dubourg, O., Kuhl, U., Maisch, B., McKenna, W.J., Monserrat, L., Pankuweit, S., Rapezzi, C., Seferovic, P., Tavazzi, L., and Keren, A. (2008). Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29, 270-276.
11. Henriksen, P.A., and Newby, D.E. (2003). Therapeutic inhibition of tumour necrosis factor alpha in patients with heart failure: cooling an inflamed heart. Heart 89, 14-18.
12. Hershberger, R.E., Morales, A., and Siegfried, J.D. (2010). Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals. Genet Med 12, 655-667.
13. Higgins, J.P., Thompson, S.G., Deeks, J.J., and Altman, D.G. (2003). Measuring inconsistency in meta-analyses. BMJ 327, 557-560.
14. Huijun, M., Ji, Z., Ping, X., Jingyu, C., and Bin, Z. (2012). Linkage disequilibrium between TNF-a-308 G/A promoter and histocompatibility leukocyte antigen alleles in Hannationality lung transplant recipients from eastern China. Exp Clin Transplant doi: 10.6002/ect.2012.0099 [Epub ahead of print].
15. Ioannidis, J.P., Trikalinos, T.A., Ntzani, E.E., and Contopoulos- Ioannidis, D.G. (2003). Genetic associations in large versus small studies: an empirical assessment. Lancet 361, 567-571.
16. Irwin, M.W., Mak, S., Mann, D.L., Qu, R., Penninger, J.M., Yan, A., Dawood, F., Wen, W.H., Shou, Z., and Liu, P. (1999). Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 99, 1492-1498.
17. Ito, M., Takahashi, H., Fuse, K., Hirono, S., Washizuka, T., Kato, K., Yamazaki, F., Inano, K., Furukawa, T., Komada, M., and Aizawa, Y. (2000). Polymorphisms of tumor necrosis factor-(alpha) and interleukin-10 genes in Japanese patients with idiopathic dilated cardiomyopathy. Jpn Heart J 41, 183-191.
18. Javor, J., Ferencik, S., Bucova, M., Stuchlikova, M., Martinka, E., Barak, L., Strbova, L., Grosse-Wilde, H., and Buc, M. (2010). Polymorphisms in the genes encoding TGF-beta1, TNF-alpha, and IL-6 show association with type 1 diabetes mellitus in the Slovak population. Arch Immunol Ther Exp (Warsz) 58, 385-393.
19. Kamizono, S., Yamada, K., Seki, N., Higuchi, T., Kimura, A., Nonaka, K., and Itoh, K. (2000). Susceptible locus for obese type 2 diabetes mellitus in the 5¢-flanking region of the tumor necrosis factor-alpha gene. Tissue Antigens 55, 449-452.
20. Kubota, T., McTiernan, C.F., Frye, C.S., Slawson, S.E., Lemster, B.H., Koretsky, A.P., Demetris, A.J., and Feldman, A.M. (1997). Dilated cardiomyopathy in transgenic mice with cardiac- specific overexpression of tumor necrosis factor-alpha. Circ Res 81, 627-635.
21. Kurrelmeyer, K.M., Michael, L.H., Baumgarten, G., Taffet, G.E., Peschon, J.J., and Sivasubramanian, N. (2000). Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci U S A 97, 5456-5461.
22. Lau, J., Ioannidis, J.P., and Schmid, C.H. (1997). Quantitative synthesis in systematic reviews. Ann Intern Med 127, 820-826.
23. Li, X., Luo, R., Jiang, R., Chen, R., and Hua, W. (2012). Human leukocyte antigen-DQ beta 1 chain (DQB1) gene polymorphisms are associated with dilated cardiomyopathy: a systematic review and meta-analysis. Heart Lung 41, 360-367.
24. Li, Y.Y., Feng, Y.Q., Kadokami, T., McTiernan, C.F., Draviam, R., and Watkins, S.C. (2000). Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by antitumor necrosis factor alpha therapy. Proc Natl Acad Sci U S A 97, 12746- 12751.
25. Liang, W.B., Lv, M.L., Su, X.W., Gao, L.B., Fang, W.L., Luo, H.B., and Zhang, L. (2010). Association of tumor necrosis factor gene polymorphisms with susceptibility to dilated cardiomyopathy in a Han Chinese population. DNA Cell Biol 29, 625- 628.
26. Luk, A., Ahn, E., Soor, G.S., and Butany, J. (2009). Dilated cardiomyopathy: a review. J Clin Pathol 62, 219-225.
27. Maron, B.J., Towbin, J.A., Thiene, G., Antzelevitch, C., Corrado, D., Arnett, D., Moss, A.J., Seidman, C.E., and Young, J.B. (2006). Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113, 1807-1816.
28. Mohan, S.B., Parker, M., Wehbi, M., and Douglass, P. (2002). Idiopathic dilated cardiomyopathy: a common but mystifying cause of heart failure. Cleve Clin J Med 69, 481-487.
29. Monden, Y., Kubota, T., Inoue, T., Tsutsumi, T., Kawano, S., Ide, T., Tsutsui, H., and Sunagawa, K. (2007). Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction. Am J Physiol Heart Circ Physiol 293, H743-753.
30. Murphy, R.T., and Starling, R.C. (2005). Genetics and cardiomyopathy: where are we now? Cleve Clin J Med 72, 465-466, 469-470, 472-483.
31. Nakano, M., Knowlton, A.A., Dibbs, Z., and Mann, D.L. (1998). Tumor necrosis factor alpha confers resistance to hypoxic injury in the adult mammalian cardiac myocyte. Circulation 97, 1392-1400.
32. Ntzani, E.E., Rizos, E.C., and Ioannidis, J.P. (2007). Genetic effects versus bias for candidate polymorphisms in myocardial infarction: case study and overview of large-scale evidence. Am J Epidemiol 165, 973-984.
33. Palka, P., Lange, A., and Burstow, D.J. (2003). Different presentation of hypertrophic cardiomyopathy in monozygotic twins. Heart 89, 751.
34. Petitti, D.B. (1994). Statistical methods in meta-analysis. In Meta- Analysis, Decision Analysis, and Cost-Effectiveness Analysis. D.B. Petitti, ed. (Oxford, New York), Chapter 7, pp. 90-114.
35. Ruppert, V., Meyer, T., Pietz, D., Perrot, A., Posch, M., Richter, A., Oezcelik, C., Maisch, B., and Pankuweit, S. (2010). The 308G/A polymorphism in the promoter of the TNF-alpha gene is associated with dilated cardiomyopathy. Eur J Heart Fail (Supplement) 9, S149 (abstract).
36. Semb, H., Peterson, J., Tavernier, J., and Olivecrona, T. (1987). Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J Biol Chem 262, 8390-8394.
37. Spiroska, V., Kedev, S., Antov, S., Trajkov, D., Petlichkovski, A., Hristomanova, S., Djulejic, E., Paneva, M., Senev, A., and Spiroski, M. (2009). Association between 22 cytokine gene polymorphisms and dilated cardiomyopathy in Macedonian patients. Kardiol Pol 67, 1237-1247.
38. Thakkinstian, A., McElduff, P., D'Este, C., Duffy, D., and Attia, J. (2005a). A method for meta-analysis of molecular association studies. Stat Med 24, 1291-1306.
39. Thakkinstian, A., McEvoy, M., Chakravarthy, U., Chakrabarti, S., McKay, G.J., Ryu, E., Silvestri, G., Kaur, I., Francis, P., Iwata, T., Akahori, M., Arning, A., Edwards, A.O., Seddon, J.M., and Attia, J. (2012). The association between complement component 2/complement factor b polymorphisms and agerelated macular degeneration: a HuGE review and metaanalysis. Am J Epidemiol 176, 361-372.
40. Thakkinstian, A., McEvoy, M., Minelli, C., Gibson, P., Hancox, B., Duffy, D., Thompson, J., Hall, I., Kaufman, J., Leung, T., Helms, P.J., Hakonarson, H., Halpi, E., Navon, R., and Attia, J. (2005b). Systematic review and meta-analysis of the association between b2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 162, 201-211.
41. Thakkinstian, A., McKay, G.J., McEvoy, M., Chakravarthy, U., Chakrabarti, S., Silvestri, G., Kaur, I., Li, X., and Attia, J. (2011). Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol 173, 1365-1379.
42. Tiret, L., Mallet, C., Poirier, O., Nicaud, V., Millaire, A., Bouhour, J.B., Roizes,G., Desnos,M., Dorent, R., Schwartz,K., Cambien, F., and Komajda, M. (2000). Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study. J Am Coll Cardiol 35, 29-35.
43. Torre-Amione, G., Kapadia, S., Lee, J., Durand, J.B., Bies, R.D., Young, J.B., and Mann, D.L. (1996). Tumor necrosis factoralpha and tumor necrosis factor receptors in the failing human heart. Circulation 93, 704-711.
44. Wang, Q., Liao, Y., Gong, F., Mao, H., and Zhang, J. (2000). HLA-DRB1 gene polymorphism in patients with dilated cardiomyopathy. J Tongji Med Univ 20, 141-142.
45. Wilson, A.G., Symons, J.A., McDowell, T.L., McDevitt, H.O., and Duff, G.W. (1997). Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94, 3195- 3199.
46. Wlodarska, E.K., Konka, M., Zaleska, T., Ploski, R., Cedro, K., Pucilowska, B., Bekiesinska-Figatowska, M., Rydlewska- Sadowska, W., Ruzyllo, W., and Hoffman, P. (2005). Arrhythmogenic right ventricular cardiomyopathy in two pairs of monozygotic twins. Int J Cardiol 105, 126-133.